This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Study Finds Proof Of Acupuncture Success

DUBLIN, December 6, 2012 /PRNewswire/ --

Acupuncture has been long been lauded by many who are convinced of its positive effect on pain. It appears that such claims can be backed up by a certain amount of technical research after a team at the University of Southampton conducted a study into the role acupuncture plays in the field of pain management.

Millions of people around the world suffer from chronic pain and pain management teams have been working on all sorts of strategies to help them deal with their own individual complaints. The strategies vary and take into account all sorts of methods, from drug therapy to physical therapy.

Acupuncture is another technique that many sufferers of chronic pain swear by and the team in Southampton, led by Professor George Lewith, have looked at a host of cases of back pain, neck pain and joint pain in a bid to assess the efficacy of this popular alternative treatment.

The results of the study made positive reading for clinics such as Fitzwilliam Health Clinic. The patients who were treated using acupuncture to supplement other techniques tended to find that their pain was eased alleviated more effectively than that of patients who received no acupuncture alongside their usual pain management regimes.

Fitzwilliam Health Clinic has been providing acupuncture alongside other forms of chiropractic, massage and physical therapy treatments for years and it has built up an excellent reputation for dealing with pain.

Patients already visit http://www.fitzwilliamhealth.ie to seek advice and treatment for complaints of all kinds and acupuncture is one of the most sought after therapies available at the clinic. It is expected that the site will see even more traffic in the future as acupuncture receives more attention in light of recent studies into its efficacy as a treatment for chronic pain.

One of the drawbacks for acupuncture tends to be a widespread sense of scepticism about whether it has the desired effect. However, Professor Lewith, who took charge of the study at the University of Southampton, stated:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs